1. Abstract
The Harris Hip Score (HHS) is an established clinician-administered and patient-reported outcome measure developed in 1969 by orthopedic surgeon William H. Harris. Originally designed to evaluate the outcomes of hip salvage surgeries, mold arthroplasty, and total hip arthroplasty (THA), the instrument assesses therapeutic efficacy across four primary clinical domains: pain severity, physical function (comprising gait mechanics and daily functional activities), absence of deformity, and range of motion. The tool yields a cumulative quantitative score ranging from 0 to 100 points, categorized qualitatively into poor (<70), fair (70–79), good (80–89), and excellent (90–100) functional outcomes. Structurally, the HHS allocates a maximum of 44 points to pain, 47 points to functional mobility (33 points for gait parameters and 14 points for daily living tasks), 4 points for anatomical alignment and absence of contractures, and 5 points for measured active and passive range of motion. Across more than five decades of clinical investigation, the HHS has demonstrated robust psychometric properties, exhibiting high test-retest reliability (intraclass correlation coefficients typically ranging between 0.91 and 0.98), strong internal consistency in postoperative orthopedic cohorts, and solid convergent validity with contemporary patient-reported measures such as the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Oxford Hip Score (OHS), and the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36). Despite its historical prominence and widespread adoption in orthopedic registries and clinical trials, modern psychometric appraisals using Item Response Theory (IRT) and Rasch analysis have highlighted notable ceiling effects in postoperative long-term follow-ups, construct multidimensionality, and variability between clinician-assessed deformity/motion metrics and subjective patient-reported functional status. This article provides a comprehensive evaluation of the HHS, detailing its theoretical foundation, psychometric architecture, clinical utility, and contemporary diagnostic applications.
2. Keywords
Harris Hip Score, total hip arthroplasty, osteoarthritis, orthopedic assessment, psychometrics, gait function, joint range of motion, clinical outcome measure, construct validity, patient-reported outcome measures.
3. Authors
The Harris Hip Score was developed by Dr. William H. Harris, M.D., an American orthopedic surgeon and researcher based at the Massachusetts General Hospital and Harvard Medical School in Boston, Massachusetts. Dr. Harris served as the Director of the Orthopaedic Biomechanics and Biomaterials Laboratory (OBBL) and held the position of Alan Gerry Clinical Professor of Orthopaedic Surgery at Harvard Medical School. Internationally recognized as a pioneer in hip replacement biomechanics, prosthetic loosening mechanisms, and thromboembolic prophylaxis, Dr. Harris introduced the scoring system to establish objective, standardized criteria for evaluating prosthetic hip implant efficacy. In subsequent decades, standardized adaptations, observer guidebooks, and cross-cultural linguistic validations—including the Dutch clinical version—were systematically coordinated by orthopedic and physical therapy academic centers, notably the VU University Medical Center Amsterdam (VU medisch centrum Amsterdam, now part of Amsterdam University Medical Centers) in the Netherlands.
4. Purpose
The primary purpose of the Harris Hip Score is to provide an objective, standardized, and repeatable metric for quantifying disability, pain severity, functional impairment, and structural recovery in adult and elderly patients presenting with hip joint pathology, primarily coxarthrosis (osteoarthritis of the hip), inflammatory hip arthritis, femoral neck fractures, osteonecrosis of the femoral head, and post-traumatic hip degeneration. Developed initially to assess outcomes following mold arthroplasty and early total hip replacement procedures, the instrument serves dual roles in orthopedic surgery: as an evaluative tool to monitor longitudinal recovery pre- and post-intervention, and as an epidemiological benchmark in clinical registries and biomedical implant safety surveillance.
Clinically, musculoskeletal disorders of the lower extremity compromise core functional biomechanics, inducing compensatory gait deviations, antalgic patterns, muscular atrophy, and chronic joint pain. By combining objective physical examination findings—specifically passive joint range of motion and fixed structural deformities—with structured patient inquiries regarding pain intensity, walking distance, assistive device utilization, and activities of daily living (ADLs), the HHS provides clinicians with a composite index reflecting both anatomical-pathological status and functional capacity. The time horizon of the instrument targets symptoms and functional capabilities experienced over the past week, capturing habitual capacity rather than fleeting acute fluctuations.
In clinical trials and comparative effectiveness research, the HHS facilitates the benchmarking of surgical approaches (e.g., direct anterior versus posterolateral approaches), novel biomaterials (e.g., highly cross-linked polyethylene, ceramic bearing surfaces), and pharmacotherapeutic or physical rehabilitation regimens. It captures the transition from preoperative debility to postoperative functional restoration, enabling researchers to quantify effect sizes, calculate minimum clinically important differences (MCID), and identify implant failure or aseptic loosening indicated by secondary declines in overall score.
5. Psychological Construct
Although widely classified within orthopedic medicine as a biomechanical and clinical rating index, the Harris Hip Score conceptually operationalizes the psychological and behavioral impacts of chronic musculoskeletal disease through the lens of pain perception, self-efficacy, health-related functional behavior, and physical disability. The instrument comprises four primary domains, each targeting a distinct manifestation of chronic joint disease:
Pain Domain (44 Maximum Points)
The pain subscale represents the single largest weighted component of the HHS, assigning up to 44% of the total score to subjective nociceptive experience. Chronic musculoskeletal pain fundamentally shapes psychological well-being, cognitive appraisal, and behavioral engagement. The HHS assesses pain severity through an ordinal hierarchy that captures intensity, frequency, interference with occupational and leisure tasks, and pharmacologic dependency. The construct differentiates between complete freedom from pain (“None or ignores it”, 44 points), tolerable discomfort necessitating concessions in average activities (“Moderate pain”, 20 points), and debilitating, refractory discomfort that renders the patient bedridden or incapacitated (“Totally disabled”, 0 points). This weighting mirrors health economics and psychometric assumptions that persistent pain constitutes the predominant motivator for elective surgical intervention.
Function: Gait Subscale (33 Maximum Points)
Functional mobility in the HHS is operationalized through three observable and self-reported gait dimensions:
- Limp (11 points): Measures observable gait asymmetry and antalgic deviations resulting from abductor muscle insufficiency (Trendelenburg gait) or pain avoidance.
- Support (11 points): Quantifies the patient’s behavioral reliance on external assistive devices (canes, crutches), reflecting compensatory postural stabilization and unloading behaviors.
- Distance Walked (11 points): Measures functional aerobic endurance and physical community mobility, graded from unlimited ambulation to complete confinement to bed and chair.
Function: Activities of Daily Living (14 Maximum Points)
This subscale assesses patient agency and self-efficacy in navigating standard environmental and personal maintenance tasks. It explicitly probes stair negotiation (4 points), foot hygiene and dressing capabilities such as putting on shoes and socks (4 points), prolonged sitting tolerance across ordinary and adapted seating (5 points), and the capacity to access public transit systems (1 point). These items capture multidirectional hip flexion, internal/external rotation, and trunk-pelvic dissociation required for functional independence.
Deformity (4 Maximum Points)
The deformity domain is an objective anatomical composite evaluating the absence of structural malalignment. To receive the full 4 points, the patient must simultaneously satisfy four clinical criteria: fixed flexion contracture of less than 30 degrees, fixed adduction of less than 10 degrees, fixed internal rotation in extension of less than 10 degrees, and structural limb length discrepancy of less than 3.2 cm (1.5 inches). Failure to satisfy any one of these criteria drops the domain score to 0, operating as a binary pass/fail gatekeeper for anatomical preservation.
Range of Motion (5 Maximum Points)
The range of motion domain quantifies active and passive arc movement across five planes: flexion, abduction, external rotation, internal rotation, and adduction. Using established weighting indices, goniometric degrees are converted into an aggregate movement index scaled from 0 to 5 points. This domain operationalizes the biomechanical flexibility of the joint capsule and surrounding periarticular musculature.
6. Theoretical Framework
The conceptual architecture of the Harris Hip Score is grounded in classical biomedical functionalism and aligns directly with the evolutionary concepts later codified by the World Health Organization in the International Classification of Functioning, Disability and Health (ICF). When Dr. William Harris designed the scale in 1969, clinical evaluation was predominantly surgeon-centric, relying heavily on radiographic bone remodeling, implant stability, and subjective narrative impressions. Harris proposed a calibrated paradigm shift by asserting that reconstructive success must be determined by a synthesized index balancing symptomatic relief, performance capacity, and objective physical examination parameters.
Under the ICF theoretical model, health status is conceptualized across three interdependent levels:
- Body Functions and Structures: Reflected in the HHS through the objective assessment of anatomical deformity (contractures and leg length discrepancies) and physical range of motion limitations.
- Activity Limitations: Operationalized through specific daily tasks (navigating stairs, donning footwear, sitting duration) and ambulatory gait thresholds (limp, walking radius).
- Participation Restrictions: Captured through items examining public transportation access, vocational and recreational compromises due to pain, and social mobility.
From a behavioral and psychometric perspective, the scale is rooted in compensatory behavioral adaptation models. As hip joint degradation advances, individuals exhibit functional concessions—initially substituting gait patterns, then adopting assistive walking aids, curtailing ambulation distance, and ultimately experiencing profound psychological distress and occupational cessation. The structural weighting of the HHS mirrors this hierarchy: pain relief and functional ambulation collectively account for 91% of the total score, directly embodying the theoretical premise that patient well-being and clinical utility in arthroplasty are governed fundamentally by symptomatic alleviation and functional re-enablement rather than isolated angular joint mobility.
7. Validity
The psychometric validity of the Harris Hip Score has been extensively evaluated across diverse international patient cohorts undergoing both primary and revision hip arthroplasty, femoral osteotomies, and conservative management for osteoarthritis.
Construct and Convergent Validity
Numerous cross-sectional and longitudinal validation studies have demonstrated moderate-to-high convergent validity between the HHS and other established hip-specific instruments. Correlational analyses with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) show Pearson and Spearman correlation coefficients typically ranging from r = -0.65 to -0.82 (in which negative correlations reflect the inverse scoring direction of the WOMAC, where higher scores indicate worse pathology). Similarly, comparisons with the Oxford Hip Score (OHS) exhibit strong positive correlations (r = 0.70 to 0.85). When evaluated against generic health-related quality of life measures, the HHS correlates robustly with the Physical Functioning (r = 0.65–0.78) and Bodily Pain (r = 0.60–0.75) subscales of the SF-36, while demonstrating discriminant validity through low correlations with SF-36 mental health and role emotional domains (r = 0.20–0.35).
Predictive and Discriminative Validity
The HHS demonstrates significant discriminative ability, reliably differentiating between varying stages of radiographic osteoarthritis (Kellegren-Lawrence grades I through IV) and clearly distinguishing pre-intervention cohorts from post-surgical cohorts. In predictive validity studies, preoperative HHS values and 6-month postoperative trajectories demonstrate utility in predicting long-term implant survival and patient satisfaction. Receiver operating characteristic (ROC) curves assessing the ability of the HHS to detect clinically meaningful patient improvement typically yield areas under the curve (AUC) exceeding 0.85, confirming strong responsiveness and diagnostic accuracy.
Ceiling and Floor Effects
While floor effects are virtually non-existent in preoperative cohorts due to the sensitivity of the pain and gait subscales, modern psychometric reviews consistently report substantial ceiling effects in long-term follow-up cohorts. In post-THA populations assessed 2 to 5 years after surgery, between 30% and 55% of patients achieve scores greater than 95 points, limiting the scale’s capacity to discriminate high-level physical performance or subtle functional decline in active elderly or younger athletic populations.
8. Reliability
The reliability of the Harris Hip Score has been verified across test-retest, inter-rater, and intra-rater testing paradigms:
Test-Retest and Inter-Rater Reliability
Evaluation of the HHS in stable clinical cohorts has shown high test-retest reliability. Intraclass correlation coefficients (ICC) across repeated administrations within 1 to 2 weeks consistently range from 0.91 to 0.98 for the total score. When partitioned into subcomponents, the pain domain and gait subscales exhibit the highest reliability indices (ICC > 0.90), whereas goniometric range of motion assessments show slightly lower, yet clinically acceptable, coefficients (ICC = 0.75 to 0.86) due to natural measurement variations across independent examiners.
Inter-rater reliability between different clinicians (e.g., orthopedic surgeons, physical therapists, and trained clinical research coordinators) demonstrates high reproducibility, with published ICCs ranging from 0.88 to 0.95. Standard error of measurement (SEM) calculations in primary osteoarthritis cohorts range between 3.2 and 4.5 points on the 100-point scale. The Minimal Detectable Change (MDC) at the 95% confidence level is generally established between 7.9 and 11.0 points, indicating that a score change exceeding 11 points represents true clinical alteration beyond measurement error.
Internal Consistency
Studies evaluating the internal consistency of the HHS have reported overall Cronbach’s alpha coefficients between 0.78 and 0.88. Although these values suggest solid internal coherence, the composite nature of the scale—which combines subjective pain reports, observational gait performance, and goniometric physical measurement—introduces multidimensional variance that slightly attenuates internal consistency relative to pure unidimensional scales.
9. Factor Analysis
Structural evaluations using both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA), as well as modern Rasch measurement models, have provided critical insights into the internal architecture of the Harris Hip Score.
Factor Structure and Model Fit
Initial exploratory factor analyses of the HHS have consistently demonstrated that the scale does not conform to a single unidimensional construct. Instead, factor solutions typically extract two or three predominant latent factors:
- Factor 1: Subjective Pain and Functional Limitation. This dominant factor accounts for the largest proportion of total variance (often 38% to 48%) and demonstrates high factor loadings (>0.70) for pain intensity, walking distance, limp, and stair negotiation.
- Factor 2: Basic Physical Self-Care / Daily Independence. This factor captures activities of daily living, specifically loading heavily on the ability to manage shoes and socks, sit comfortably, and use public transit.
- Factor 3: Objective Mechanical Impairment. This dimension loads primarily on fixed deformity criteria and goniometric range of motion indices, accounting for roughly 8% to 12% of total variance.
Confirmatory factor analyses testing a three-factor oblique model consistently show superior fit indices compared to a one-factor model, with Comparative Fit Index (CFI) values exceeding 0.93, Tucker-Lewis Index (TLI) > 0.91, and Root Mean Square Error of Approximation (RMSEA) < 0.07. These structural findings corroborate clinical observations that physical range of motion and absence of mild contractures can vary independently from a patient’s subjective pain experience and functional walking tolerance.
Item Response Theory and Rasch Analyses
Modern Rasch analyses have demonstrated that the response categories within certain items (such as sitting tolerance and public transportation) exhibit category disordering or underutilization, indicating that fewer response thresholds may provide better measurement precision. Furthermore, differential item functioning (DIF) has been detected across age strata, particularly within the public transportation and stairs items, where elderly patients often record functional compromises unrelated directly to hip joint pathology.
10. Instrument / Measurement Tool
- Test Type: Clinician-administered performance assessment combined with structured patient-reported inquiry.
- Format: Clinical rating scale, physical examination protocol, and structured diagnostic interview.
- Item Count: 10 distinct clinical evaluation domains evaluating 100 maximum scaled points.
- Administration Time: Approximately 10 to 15 minutes, including goniometric evaluation and physical deformity screening.
- Target Population: Adults and elderly individuals presenting with hip osteoarthritis, femoral head osteonecrosis, fractures, or undergoing total hip arthroplasty.
- Authentic Response Scale: Point allocation per category (total score ranges from 0 to 100 points).
- Scoring and Weighting Structure:
- Pain Domain: Maximum 44 points.
- Function Domain: Maximum 47 points (Gait = 33 points, Functional Activities = 14 points).
- Deformity Domain: Maximum 4 points (Binary: 4 points if all four anatomical criteria are met, 0 points if any criterion fails).
- Range of Motion Domain: Maximum 5 points (Calculated movement index based on goniometric degrees across 5 movement planes).
- Clinical Grading Scale:
- <70 points: Poor outcome / severe functional impairment.
- 70–79 points: Fair outcome / moderate functional limitation.
- 80–89 points: Good outcome / mild impairment.
- 90–100 points: Excellent outcome / normal or near-normal hip joint function.
11. Permissions & Fee and Test Year
The Harris Hip Score was first published in 1969 by Dr. William H. Harris in The Journal of Bone and Joint Surgery (American Volume). As a historic assessment system published in open scientific literature, the instrument is generally considered to reside in the public domain for clinical and academic research purposes. No licensing fees or proprietary per-use royalty payments are required to administer the scale in clinical practice or academic trials. However, investigators utilizing localized or cross-culturally validated translations—such as the Dutch adaptation maintained by institutions such as the VU University Medical Center Amsterdam (VU medisch centrum)—should appropriately reference the original 1969 publication and the respective institutional validation studies. Commercial clinical trial sponsors utilizing electronic clinical outcome assessment (eCOA) implementations frequently consult with academic copyright administrators to ensure fidelity to standardized item wording and scoring routines.
12. References
- Harris, W. H. (1969). Traumatic arthritis of the hip after dislocation and acetabular fractures: Treatment by mold arthroplasty: An end-result study using a new method of result evaluation. The Journal of Bone & Joint Surgery, 51(4), 737–755. https://doi.org/10.2106/00004623-196951040-00012
- Mahomed, N. N., Arndt, D. C., McGrory, B. J., & Harris, W. H. (2001). The Harris Hip Score: Comparison of patient self-report with medical staff assessment. The Journal of Arthroplasty, 16(5), 575–580. https://doi.org/10.1054/arth.2001.23719
- Nilsdotter, A., & Bremander, A. (2011). Measures of hip function and symptoms: Harris Hip Score (HHS), Hip Disability and Osteoarthritis Outcome Score (HOOS), Oxford Hip Score (OHS), Lequesne Index of Severity for Osteoarthritis of the Hip (LISOH), and American Academy of Orthopedic Surgeons (AAOS) Lower Limb Questionnaire. Arthritis Care & Research, 63(S11), S200–S207. https://doi.org/10.1002/acr.20549
- Soderman, P., & Malchau, H. (2001). Is the Harris hip score system reliable? A study of 39 patients with 56 total hip replacements. Acta Orthopaedica Scandinavica, 72(3), 248–251. https://doi.org/10.1080/00016470152846565
- Wamper, K. E., Sierevelt, I. N., Poolman, R. W., Bhandari, M., & Haverkamp, D. (2014). The Harris hip score: Do doctors and patients agree? The Journal of Arthroplasty, 29(4), 725–730. https://doi.org/10.1016/j.arth.2013.08.016